Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.
about
A systematic review to investigate whether Angiotensin-(1-7) is a promising therapeutic target in human heart failureOcular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in RatsOral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunctionFrom gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertensionAngiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathwaysNew insight into the molecular drug target of diabetic nephropathy.New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.Angiotensin-converting enzyme 2: the first decade.ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease TherapyAngiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro.Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina.Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes.ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathwaysAngiotensin-converting enzyme 2 activation improves endothelial functionAntiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.Association of exercise training and angiotensin-converting enzyme 2 activator improves baroreflex sensitivity of spontaneously hypertensive ratsNew agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats.Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitroEmerging drugs which target the renin-angiotensin-aldosterone system.New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system.Pathophysiological role of the renin-angiotensin system on erectile dysfunction.Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling. Fan, ACE2 improves atrial substrate remodeling.New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?Future drug discovery in renin-angiotensin-aldosterone system intervention.The effect of the thioether-bridged, stabilized Angiotensin-(1-7) analogue cyclic ang-(1-7) on cardiac remodeling and endothelial function in rats with myocardial infarction.Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease.Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction.Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.
P2860
Q27021559-E1FEA9A3-05D8-4E4F-9876-A1F585F5709BQ28546739-4A3ABDEB-D1AC-406A-8044-D1BBE59E6124Q28569684-9CE6A5B6-F2E5-49DF-BE77-5267AB50CDA0Q33795353-AC544517-0A39-401D-9D60-B0CE5CEDCAC9Q35040846-F2088534-E436-409D-B768-14815A6896B1Q35125585-5B34971E-3734-4B87-B30A-EA991CA3F2A2Q35137270-A85A00B3-6A6F-4B44-919E-3C78A79FCA6EQ35484295-1BF3AC30-C9A9-4C4A-891A-1B516A05AB52Q35550937-6F4F26C2-91EA-4CC9-9034-0953F074CAE7Q35760437-9E95DC64-0C85-441E-B060-9F2ED9D8D8F2Q35889735-6ED60075-8D96-490F-A3F4-672DB6EE5161Q36096985-2EF13A2E-2057-413F-9D0C-F5F665366303Q36185540-530C3410-8911-411D-B588-082F438C29D6Q36322296-15E6D4CC-4794-44CE-A753-94D2BF0A79FCQ36410637-5615B45F-EA41-48B1-A073-58DD05A51C2BQ36929414-9F4FB83F-35A2-4E65-9445-D563A5C7F1B2Q37005635-4652326A-C0FA-460B-A1DB-C48725864415Q37069541-FC07FC1C-61D4-4905-BF4D-0B1EAC6B4899Q37085063-EE95D2C6-486B-4982-BCCA-1B62DB16BDDFQ37183375-D907ADDC-A818-4B19-8E8F-D104F35054E1Q37347190-30A05D4E-F2CA-432A-8AC0-8C875B490573Q37657817-E27F953D-3F89-4656-968F-06BBCDC54E60Q37731227-DF6120A1-4A3C-4D62-A302-1B6942108ABEQ37929786-40FE84B0-B8F3-4929-B1A5-13AC22D1972BQ37982718-EA8AE631-1634-44E1-828A-42B485AC71BCQ38003191-D8FF7322-2BFE-416A-861D-AF4C3541BF43Q38065112-C8FDC33F-EA4D-44B4-97FE-EF38FF9A47AEQ38069197-8062B3F3-2525-4827-B43D-5D59B36039F3Q38126111-94CDB1BC-1AE1-406C-A7FF-0B077469979DQ38193206-65396558-9B72-4D5B-99CD-26A718A1ED03Q38207841-75AFA212-D415-4C01-AB5D-9A1CC3FBA99AQ38413814-A62C77B8-2D58-41EF-90BF-6D3352C0A896Q38429870-B0DFC770-C6ED-46D7-872B-671C9A49121AQ38679303-E5EA2340-C75E-41E1-B9DD-D09755269541Q38896798-2CCECD17-8CA3-4497-96A3-17BD6F675D41Q39221569-184D4FB6-DE12-4C66-AB92-3FA7A08F4730Q39599579-B8CEDF88-67B4-4328-B7FD-0CF48F75F4A1Q41572699-F1D227C5-83BF-4254-969A-80A42BA48F3AQ42031141-470F89DB-1771-452C-987E-655A5D7829E8Q42124925-ED8CC91C-96A2-432D-B5A8-0FF977177716
P2860
Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@ast
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@en
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@nl
type
label
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@ast
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@en
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@nl
prefLabel
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@ast
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@en
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@nl
P2093
P2860
P1476
Angiotensin-converting enzyme ...... ular signal-regulated kinases.
@en
P2093
Anderson J Ferreira
Michael J Katovich
Mohan K Raizada
Robson A S Santos
Rodrigo A Fraga-Silva
Vinayak Shenoy
P2860
P304
P356
10.1113/EXPPHYSIOL.2010.055277
P577
2010-12-10T00:00:00Z